Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 5Phase 1/2 3Phase NA 2Phase EARLY_PHASE1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Recurrence 1Neoplasms 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Childhood Solid Tumor 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 155Carboplatin 147Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 119Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Cell- and Tissue-Based Therapy × Clear all
NCT06096038 2026-02-20

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Recruiting
33 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Recurrence

NCT01947322 2017-08-29

NK

Assistance Publique - Hôpitaux de Paris

Phase 1/2 Completed
10 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01337544 2013-11-11

NK

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Phase 1/2 Terminated
6 enrolled
Other solid neoplasm

Childhood Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡